This content is machine translated Multiple Myeloma and MDS Something has happened in therapy The diagnosis and treatment of multiple myeloma (MM) and myelodysplastic syndromes (MDS) have undergone great development in recent years. Modern diagnostic procedures became qualitatively better and more widely available, new…
View Post 4 min This content is machine translated HER2-positive breast cancer and lymphoma New applications and antibodies The antibody-drug conjugate trastuzumab emtansine, T-DM1 (Kadcyla®), is composed of the antibody trastuzumab and the chemotherapeutic agent DM1 and is currently being investigated for the treatment of HER2-positive cancers. It…
View Post 3 min This content is machine translated Actinic keratosis Physicians should reconsider their therapy habits At this year’s Melanoma Congress in Hamburg, the question was raised whether the most commonly used treatment options for actinic keratosis (AK) are the most effective and cost-effective. Furthermore, the…
View Post 2 min This content is machine translated 10 years GIST Group Switzerland GIST – a life with cancer Since 2004, the patient organization “GIST Group Switzerland” (www.gist.ch) has been supporting patients with gastrointestinal stromal tumors (GIST) and their families. This year’s annual meeting offered a special program for…
View Post 2 min This content is machine translated On our own account We stand for topicality Dear readers
View Post 3 min This content is machine translated WCM Congress Basal cell carcinoma – What therapies are available for advanced forms? New avenues in the treatment of basal cell carcinoma (BCC) are being intensively discussed by current researchers. In particular, the functioning and inhibition of the Hedgehog signaling pathway offers an…
View Post 3 min This content is machine translated Oral tumor therapy Preliminary results of a pilot project to improve patient communication. The pilot project “Patient communication in oral tumor therapy to promote adherence” will evaluate whether targeted communication training for nurses and physicians adds value for patients and the healthcare professionals…
View Post 3 min This content is machine translated Highlights from the ASCO Congress New treatment options for melanoma At the ASCO Congress, updates on immunotherapy and kinase inhibitors in melanoma were among the topics presented. Current research is yielding some promising insights into new treatment methods, for example…
View Post 4 min This content is machine translated Chronic lymphocytic leukemia New therapies urgently needed At the ESMO Congress in Amsterdam, speakers from various countries discussed the latest results and therapy recommendations in the field of chronic lymphocytic leukemia. Overall, chemoimmunotherapy with fludarabine, cyclophosphamide (FC),…
View Post 6 min This content is machine translated 5th Interdisciplinary Prostate Cancer Symposium Metastatic prostate cancer – New therapeutic options Prostate cancer is the most common male tumor in Western countries and is the second leading cause of cancer-related death in Switzerland. In particular, metastatic castration-resistant prostate cancer (mCRPC) is…
View Post 1 min This content is machine translated Metastatic colorectal carcinoma Determination of mutational RAS status is important in mCRC The results of the FIRE-3 study, presented at this year’s European Cancer Congress in Amsterdam, emphasize the importance and relevance of RAS mutation analysis (KRAS and NRAS) for first-line treatment…
